Imat 100 MG Tablet contains Imatinib Mesylate 100mg in a low-dose flexible formulation for patients requiring individualized dosing in CML or GIST treatment protocols.

How It Works: Imatinib occupies the ATP-binding pocket of BCR-ABL kinase, preventing substrate phosphorylation and effectively switching off the oncogenic signaling driving chronic myeloid leukemia and GIST.

Common Uses: Flexible-dose CML therapy, pediatric CML protocols, GIST dosing adjustments, and combination regimens requiring lower imatinib contributions.

Administration: Take with food and a glass of water. Tablets can be dissolved in water for patients with swallowing difficulty. Follow prescribed dosing schedule.

Storage: Store below 30°C in original blister packaging. Protect from moisture. Keep away from children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.